Aligos Therapeutics, Inc. (ALGS) vs Pluri Inc. (PLUR)
- Aligos Therapeutics, Inc. ALGS 2.10 +6.06%
- Pluri Inc. PLUR 1.05 −3.67%
Aligos Therapeutics, Inc. and Pluri Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Pluri Inc. are of similar size ($14.0M and $13.7M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 1,171.6% against 10.0%. Aligos Therapeutics, Inc. has the higher net margin (−197.0% vs −1,943.9%) and the higher return on invested capital (0.00% vs −690.2%). Across the 16 metrics below, Aligos Therapeutics, Inc. leads on 11 and Pluri Inc. on 5.
Valuation
Profitability
| Metric | ALGS | PLUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 51.95% | 67.24% |
| Operating margin | (215.55%) | (2,341.12%) | 0.00% |
| Net margin | (197.01%) | (1,943.87%) | 0.00% |
| Free cash flow margin | (204.07%) | (1,282.11%) | 0.00% |
| Return on equity | (159.46%) | 253.49% | (50.28%) |
| Return on assets | (84.46%) | (96.79%) | (45.89%) |
| Return on invested capital | 0.00% | (690.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack